Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Autoimmune Disorders

Free Subscription Articles published in J Neuroimmunol Retrieve available abstracts of 184 articles: HTML format Text format

Single Articles

January 2012
1. KALISZEWSKA A , De Jager PL
   Exploring the role of the epigenome in multiple sclerosis: A window onto cell-specific transcriptional potential.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. VILLOSLADA P , Baranzini S
   Data integration and systems biology approaches for biomarker discovery: Challenges and opportunities for multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. LISI L , Navarra P, Cirocchi R, Sharp A, et al
   Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. FOSTER M , Zivadinov R, Weinstock-Guttman B, Tamano-Blanco M, et al
   Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. STOJKOVIC L , Djuric T, Stankovic A, Dincic E, et al
   The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PINTO-MEDEL MJ , Garcia-Leon JA, Oliver-Martos B, Lopez-Gomez C, et al
   The CD4(+) T-cell subset lacking expression of the CD28 costimulatory molecule is expanded and shows a higher activation state in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MANDEL I , Paperna T, Miller A
   Aberrant expression of the apoptosis-related proteins BAK and MCL1 in T cells in multiple sclerosis.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. CUSICK MF , Libbey JE, Trede NS, Eckels DD, et al
   Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. MULS N , Jnaoui K, Dang HA, Wauters A, et al
   Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network.
   J Neuroimmunol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. BORONAT A , Sepulveda M, Llufriu S, Sabater L, et al
    Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WU LY , Zhou Y, Qin C, Hu BL, et al
    The effect of TNF-alpha, FcgammaR and CD1 polymorphisms on Guillain-Barre syndrome risk: Evidences from a Meta-Analysis.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. NEVIN RL
    Investigating channel blockers for the treatment of multiple sclerosis: Considerations with mefloquine and carbenoxolone.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
13. CHEN YC , Chen SD, Miao L, Liu ZG, et al
    Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MULERO P , Caminero AB, Neri Crespo MJ, Fernandez-Herranz R, et al
    Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. MORI S , Yamada S, Kubo S, Chen J, et al
    Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.
    J Neuroimmunol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
16. BUENAFE AC
    Diurnal rhythms are altered in a mouse model of multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BEYER NH , Lueking A, Kowald A, Frederiksen JL, et al
    Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ZHONG X , Wang H, Dai Y, Wu A, et al
    Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    J Neuroimmunol. 2011;240-241:104-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ENDONG L , Shijie J, Sonobe Y, Di M, et al
    The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells.
    J Neuroimmunol. 2011;240-241:58-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. LAUGEL B , Borlat F, Galibert L, Vicari A, et al
    Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
    J Neuroimmunol. 2011;240-241:52-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. DOBSON R , Meier UC, Giovannoni G
    More to come: humoral immune responses in MS.
    J Neuroimmunol. 2011;240-241:13-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. LALIVE PH , Molnarfi N, Benkhoucha M, Weber MS, et al
    Antibody response in MOG(35-55) induced EAE.
    J Neuroimmunol. 2011;240-241:28-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WANG H , Wang K, Zhong X, Dai Y, et al
    Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. NEIL J , Choumet V, Le Coupanec A, d'Alayer J, et al
    Guillain-Barre syndrome: First description of a snake envenomation aetiology.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. NAEGELE M , Tillack K, Reinhardt S, Schippling S, et al
    Neutrophils in multiple sclerosis are characterized by a primed phenotype.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SCERBO MJ , Bibolini MJ, Roth GA, Monferran CG, et al
    Synapsin peptide fused to E. coli heat-labile toxin B subunit induces regulatory T cells and modulates cytokine balance in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
27. TOEPFNER N , Cepok S, Grummel V, Hemmer B, et al
    The role of the Epstein-Barr Virus receptor CD21 in Multiple Sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SINGH V , Hintzen RQ, Luider TM, Stoop MP, et al
    Proteomics technologies for biomarker discovery in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. BAKER D , Amor S
    Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. CHEN M , Chen G, Deng S, Liu X, et al
    IFN-beta induces the proliferation of CD4(+)CD25(+)Foxp3(+) regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. SHENG JR , Muthusamy T, Prabhakar BS, Meriggioli MN, et al
    GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. YU X , Burgoon M, Green M, Barmina O, et al
    Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. COSTA A , Bini P, Hamze-Sinno M, Moglia A, et al
    Galanin and alpha-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ZANOTTI C , Chiarini M, Serana F, Capra R, et al
    Opposite effects of interferon-beta on new B and T cell release from production sites in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. GUERAU-DE-ARELLANO M , Alder H, Ozer HG, Lovett-Racke A, et al
    miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
36. KALINOWSKA-LYSZCZARZ A , Pawlak MA, Michalak S, Paprzycki W, et al
    Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. VICHAYA EG , Young EE, Frazier MA, Cook JL, et al
    Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release.
    J Neuroimmunol. 2011;239.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. STUBGEN JP
    Immune-mediated myelitis associated with hepatitis virus infections.
    J Neuroimmunol. 2011;239.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SRIRAM S
    Role of glial cells in innate immunity and their role in CNS demyelination.
    J Neuroimmunol. 2011;239.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. VURAL B , Ugurel E, Tuzun E, Kurtuncu M, et al
    Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease.
    J Neuroimmunol. 2011;239.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. PEELEN E , Damoiseaux J, Smolders J, Knippenberg S, et al
    Th17 expansion in MS patients is counterbalanced by an expanded CD39(+) regulatory T cell population during remission but not during relapse.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. LOSSIUS A , Vartdal F, Holmoy T
    Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. GIOVANNI F , Domenico P, Alessandro M, Raffaele I, et al
    Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KAWAMURA N , Piao H, Minohara M, Matsushita T, et al
    Campylobacter jejuni DNA-binding protein from starved cells in Guillain-Barre syndrome patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. TRAKAS N , Zisimopoulou P, Tzartos SJ
    Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. HUANG XN , Fu J, Wang WZ
    The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
47. KNIPPENBERG S , Peelen E, Smolders J, Thewissen M, et al
    Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. KUWAHARA M , Suzuki S, Takada K, Kusunoki S, et al
    Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KWOK JY , Vaida F, Augst RM, Yu DY, et al
    Mannose binding lectin mediated complement pathway in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. GAMBUZZA M , Licata N, Palella E, Celi D, et al
    Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
51. MALHOTRA S , Morcillo-Suarez C, Brassat D, Goertsches R, et al
    IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. URSHANSKY N , Mausner-Fainberg K, Auriel E, Regev K, et al
    Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. BRENNAN KM , Galban-Horcajo F, Rinaldi S, O'Leary CP, et al
    Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. RAINE CS
    John W. Prineas awarded the Order of Australia.
    J Neuroimmunol. 2011;237.
    PubMed     Text format     Related articles   
    
    
    
    
55. LUNDSTROM W , Greiner E, Lundmark F, Westerlind H, et al
    No influence on disease progression of non-HLA susceptibility genes in MS.
    J Neuroimmunol. 2011;237.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
56. SUZUKI S , Utsugisawa K, Iwasa K, Satoh T, et al
    Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. VIRTANEN JO , Pietilainen-Nicklen J, Uotila L, Farkkila M, et al
    Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. TOLDI G , Folyovich A, Simon Z, Zsiga K, et al
    Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon beta.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ZHANG Z , Zhang ZY, Schittenhelm J, Wu Y, et al
    Parenchymal accumulation of CD163(+) macrophages/microglia in multiple sclerosis brains.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. HEIDARI A , Behmanesh M, Sahraian MA, Meshkani R, et al
    The human caveolin 1 gene upstream purine complex and neurodegeneration--a common signature.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. HORAKOVA D , Zivadinov R, Weinstock-Guttman B, Havrdova E, et al
    HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. HOSOKAWA T , Nakajima H, Doi Y, Sugino M, et al
    Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. YU X , Green M, Gilden D, Lam C, et al
    Identification of peptide targets in neuromyelitis optica.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. CRANE JM , Rossi A, Gupta T, Bennett JL, et al
    Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. MARCHIONI E , Tavazzi E, Franciotta D
    ADEM as a niche variant of post infectious neurological syndromes.
    J Neuroimmunol. 2011;236.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
66. SMITH AJ , Liu Y, Peng H, Beers R, et al
    Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. RAMANUJAM R , Piehl F, Pirskanen R, Gregersen PK, et al
    Concomitant autoimmunity in myasthenia gravis - Lack of association with IgA deficiency.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SANVITO L , Tomita A, Chihara N, Okamoto T, et al
    Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-beta and interferon-beta combined with low-dose oral steroids.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. EDLING AE , Gomes D, Weeden T, Dzuris J, et al
    Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (alpha-MSH) in experimental autoimmune uveitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SAFAVI F , Feliberti JP, Raine CS, Mokhtarian F, et al
    Role of gammadelta T cells in antibody production and recovery from SFV demyelinating disease.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. LINDVALL T , Nandakumar KS, Yousefi K, Holmdahl R, et al
    An encephalomyelitis-specific locus on chromosome 16 in mouse controls disease development and expression of immune-regulatory genes.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. SAADOUN S , Waters P, Macdonald C, Bridges LR, et al
    T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. KALA M , Miravalle A, Vollmer T
    Recent insights into the mechanism of action of glatiramer acetate.
    J Neuroimmunol. 2011;235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
74. MIROWSKA-GUZEL D , Gromadzka G, Mach A, Czlonkowski A, et al
    Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-alpha polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. FORDE EA , Dogan RN, Karpus WJ
    CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. LEE S , Xu L, Shin Y, Gardner L, et al
    A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. GORIS A , Fockaert N, Cosemans L, Clysters K, et al
    TNFRSF1A coding variants in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. CHEN X , Ma X, Jiang Y, Pi R, et al
    The prospects of minocycline in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. SKARICA M , Eckstein C, Whartenby KA, Calabresi PA, et al
    Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. AHLGREN C , Oden A, Haghighi S, Andersen O, et al
    The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. CAMINERO A , Comabella M, Montalban X
    Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyelination revisited: an ongoing story.
    J Neuroimmunol. 2011;234.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. HARRER A , Wipfler P, Einhaeupl M, Pilz G, et al
    Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.
    J Neuroimmunol. 2011;234.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. DUJMOVIC I , Mader S, Schanda K, Deisenhammer F, et al
    Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
    J Neuroimmunol. 2011;234.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
84. SMOLDERS J , Thewissen M, Theunissen R, Peelen E, et al
    Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. LI Y , Wang H, Long Y, Lu Z, et al
    Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. LI J , Zhao X, Skoff R, Shaw MK, et al
    Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encelphalomyelitis in two H-2(b)-restricted mouse strains.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. QI H , Li J, Allman W, Saini SS, et al
    Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. GREER JM , McCombe PA
    Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. WILLIAMS JL , Kithcart AP, Smith KM, Shawler T, et al
    Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. MATYSIAK M , Orlowski W, Fortak-Michalska M, Jurewicz A, et al
    Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. HARA H , Nanri Y, Tabata E, Mitsutake S, et al
    Identification of astrocyte-derived immune suppressor factor that induces apoptosis of autoreactive T cells.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. REN Z , Wang Y, Liebenson D, Liggett T, et al
    IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. TUZUN E , Kurtuncu M, Turkoglu R, Icoz S, et al
    Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. GORI F , Mulinacci B, Massai L, Avolio C, et al
    IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. WANG H , Dai Y, Qiu W, Zhong X, et al
    HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. BARATCHI S , Kanwar RK, Kanwar JR
    Novel survivin mutant protects differentiated SK-N-SH human neuroblastoma cells from activated T-cell neurotoxicity.
    J Neuroimmunol. 2011;233.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
97. BIEGLER BW , Yan SX, Ortega SB, Tennakoon DK, et al
    Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. HAGMAN S , Raunio M, Rossi M, Dastidar P, et al
    Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. FERNANDEZ-MALAVE E , Stark-Aroeira L
    A natural anti-T-cell receptor monoclonal antibody protects against experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. ROTONDI M , Stufano F, Lagonigro MS, La Manna L, et al
     Interferon-beta but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: A clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs.
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. JAGER LD , Dabelic R, Waiboci LW, Lau K, et al
     The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis.
     J Neuroimmunol. 2011;232.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. TELERMAN A , Lapter S, Sharabi A, Zinger H, et al
     Induction of hippocampal neurogenesis by a tolerogenic peptide that ameliorates lupus manifestations.
     J Neuroimmunol. 2011;232.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. BEGUM-HAQUE S , Christy M, Ochoa-Reparaz J, Nowak EC, et al
     Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.
     J Neuroimmunol. 2011;232.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. MENSAH-BROWN EP , Shahin A, Al Shamisi M, Lukic ML, et al
     Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats.
     J Neuroimmunol. 2011;232.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. EBERS GC
     Gene associations - SNPs and function.
     J Neuroimmunol. 2011;232.
     PubMed     Text format     Related articles   
     
     
     
     
106. BROD SA , Hood ZM
     Ingested (oral) ACTH inhibits EAE.
     J Neuroimmunol. 2011;232.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
107. OBERMEIER B , Lovato L, Mentele R, Bruck W, et al
     Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin.
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. MCFARLAND H
     The importance of clinical trials in unraveling the mysteries of multiple sclerosis.
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. FLEMING JO
     Helminths and multiple sclerosis: Will old friends give us new treatments for MS?
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
110. WENDER M
     Acute disseminated encephalomyelitis (ADEM).
     J Neuroimmunol. 2011;231.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. FAZIO R , Radaelli M, Furlan R
     Neuromyelitis optica: concepts in evolution.
     J Neuroimmunol. 2011;231.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. LEHMANN HC , Hartung HP
     Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
     J Neuroimmunol. 2011;231.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. HOLMOY T , Geis C
     The immunological basis for treatment of stiff person syndrome.
     J Neuroimmunol. 2011;231.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
114. CORREALE J , Farez MF
     The impact of parasite infections on the course of multiple sclerosis.
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. HAEGERT DG , Hackenbroch JD, Duszczyszyn D, Fitz-Gerald L, et al
     Reduced thymic output and peripheral naive CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS).
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. HASHIBA N , Nagayama S, Araya SI, Inada H, et al
     Phenytoin at optimum doses ameliorates experimental autoimmune encephalomyelitis via modulation of immunoregulatory cells.
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. CHAUDHARY P , Marracci G, Yu X, Galipeau D, et al
     Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis.
     J Neuroimmunol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. ZAHEDNASAB H , Saadatnia M, Jabalameli MR, Zarkesh-Esfahani H, et al
     Controversial role of MMP-9 gene in MS disease.
     J Neuroimmunol. 2011;230.
     PubMed     Text format     Related articles   
     
     
     
     
119. SAND PG
     CASP8 in MS.
     J Neuroimmunol. 2011;230.
     PubMed     Text format     Related articles   
     
     
     
     December 2010
120. LYSANDROPOULOS AP , Jaquiery E, Jilek S, Pantaleo G, et al
     Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. YU X , Gilden D, Schambers L, Barmina O, et al
     Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. VROLIX K , Niks EH, Le Panse R, van Ostaijen-Ten Dam MM, et al
     Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. JARIUS S , Stich O, Speck J, Rasiah Ch, et al
     Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome.
     J Neuroimmunol. 2010;229.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. JENSEN CJ , Stankovich J, Butzkueven H, Oldfield BJ, et al
     Common variation in the MOG gene influences transcript splicing in humans.
     J Neuroimmunol. 2010;229.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. RAY A , Mann MK, Basu S, Dittel BN, et al
     A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. SAKURAI T , Kimura A, Yamada M, Koumura A, et al
     Identification of antibodies as biological markers in serum from multiple sclerosis patients by immunoproteomic approach.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
127. ESPOSITO F , Wojcik J, Rodegher M, Radaelli M, et al
     MGAT5 and disease severity in progressive multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. GROSS R , Healy BC, Cepok S, Chitnis T, et al
     Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. MILO R , Panitch H
     Combination therapy in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. URSHANSKY N , Mausner-Fainberg K, Auriel E, Regev K, et al
     Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. OLIVER-MARTOS B , Orpez T, Pinto-Medel MJ, Mayorga C, et al
     Gene expression in IFNss signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. FRANCIOTTA D , Di Stefano AL, Jarius S, Zardini E, et al
     Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. MEOLI EM , Oh U, Grant CW, Jacobson S, et al
     TGF-beta signaling is altered in the peripheral blood of subjects with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. PAL J , Rozsa C, Komoly S, Illes Z, et al
     Clinical and biological heterogeneity of autoimmune myasthenia gravis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. FARINAZZO A , Gini B, Milli A, Ruffini F, et al
     2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. SMITH AW , Doonan BP, Tyor WR, Abou-Fayssal N, et al
     Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. SUZUKI S , Utsugisawa K, Nagane Y, Satoh T, et al
     Clinical and immunological differences between early and late-onset myasthenia gravis in Japan.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. PHAM H , Doerrbecker J, Ramp AA, D'Souza CS, et al
     Experimental autoimmune encephalomyelitis (EAE) IN C57Bl/6 mice is not associated with astrogliosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. BILL R , Doring A, Deutsch U, Engelhardt B, et al
     PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
140. VOGELGESANG A , Dressel A
     Immunological consequences of ischemic stroke: Immunosuppression and autoimmunity.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. PACHNER AR , Li L, Lagunoff D
     Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. OFFNER H , Sinha S, Burrows GG, Ferro AJ, et al
     RTL therapy for multiple sclerosis: A Phase I clinical study.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. GATSON NN , Williams JL, Powell ND, McClain MA, et al
     Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. MASSILAMANY C , Thulasingam S, Steffen D, Reddy J, et al
     Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139-151 in SJL mice.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. WINER JB
     Guillain-Barre syndrome: Clinical variants and their pathogenesis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. LOSY J , Kalinowska-Lyszczarz A
     Emerging disease-modifying oral therapies for multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. MATA S , Muscas GC, Cincotta M, Bartolozzi ML, et al
     GAD antibodies associated neurological disorders: incidence and phenotype distribution among neurological inflammatory diseases.
     J Neuroimmunol. 2010;227.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. ZHANG Y , Jalili F, Ouamara N, Zameer A, et al
     Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2.
     J Neuroimmunol. 2010;227.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. PERON JP , Yang K, Chen ML, Brandao WN, et al
     Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice.
     J Neuroimmunol. 2010;227.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. TIAN Y , Apperson ML, Ander BP, Liu D, et al
     Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
151. GUERAU-DE-ARELLANO M , Lovett-Racke AE, Racke MK
     miRNAs in multiple sclerosis: Regulating the regulators.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
152. KAPLAN B , Aizenbud BM, Golderman S, Yaskariev R, et al
     Free light chain monomers in the diagnosis of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. AIZMAN E , Mor A, Chapman J, Assaf Y, et al
     The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. MURPHY TK , Storch EA, Turner A, Reid JM, et al
     Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. TRAN GT , Hodgkinson SJ, Carter NM, Killingsworth M, et al
     Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. TSCHERNATSCH M , Singh P, Gross O, Gerriets T, et al
     Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
     J Neuroimmunol. 2010;226.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. SUN B , Zhang X, Wang G, Kong Q, et al
     Regulation of suppressing and activating effects of mesenchymal stem cells on the encephalitogenic potential of MBP68-86-specific lymphocytes.
     J Neuroimmunol. 2010;226.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. BENNETT J , Basivireddy J, Kollar A, Biron KE, et al
     Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. BAHREINI SA , Jabalameli MR, Saadatnia M, Zahednasab H, et al
     The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. LI J , Zhao X, Hao HW, Shaw MK, et al
     T cells that trigger acute experimental autoimmune encephalomyelitis also mediate subsequent disease relapses and predominantly produce IL-17.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. LINDSEY JW , Hatfield LM
     Epstein-Barr virus and multiple sclerosis: Cellular immune response and cross-reactivity.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. FUSCO C , Guerini FR, Nocera G, Ventrella G, et al
     KIRs and their HLA ligands in Remitting-Relapsing Multiple Sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. CASIRAGHI C , Dorovini-Zis K, Horwitz MS
     Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
164. TRUNE DR , Kempton JB
     Low dose combination steroids control autoimmune mouse hearing loss.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. GAO HX , Sanders E, Tieng AT, Putterman C, et al
     Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. AHARONI R , Eilam R, Stock A, Vainshtein A, et al
     Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
     J Neuroimmunol. 2010;225.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. RAKOVER IS , Zabavnik N, Kopel R, Paz-Rozner M, et al
     Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope.
     J Neuroimmunol. 2010;225.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. MILLONIG A , Hegen H, Di Pauli F, Ehling R, et al
     Natalizumab treatment reduces endothelial activity in MS patients.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. YAMOUT B , Hourani R, Salti H, Barada W, et al
     Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. PAL Z , Antal P, Millinghoffer A, Hullam G, et al
     A novel galectin-1 and interleukin 2 receptor beta haplotype is associated with autoimmune myasthenia gravis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. CHAN KH , Kwan JS, Ho PW, Ho SL, et al
     Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. CHANG T , Lin H, Gao J, Li W, et al
     Selective recognition and elimination of nicotinic acetylcholine receptor-reactive B cells by a recombinant fusion protein AChR-Fc in myasthenia gravis in vitro.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. MOSTAFA GA , Ibrahim DH, Shehab AA, Mohammed AK, et al
     The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. BEESTON T , Smith TR, Maricic I, Tang X, et al
     Involvement of IFN-gamma and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. LORENTZEN AR , Melum E, Ellinghaus E, Smestad C, et al
     Association to the Glypican-5 gene in multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. WEGNER C , Stadelmann C, Pfortner R, Raymond E, et al
     Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
177. LINK J , Lorentzen AR, Kockum I, Duvefelt K, et al
     Two HLA class I genes independently associated with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. CONDUCTIER G , Blondeau N, Guyon A, Nahon JL, et al
     The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.
     J Neuroimmunol. 2010;224.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. TEIXEIRA MM , Vilela MC, Soriani FM, Rodrigues DH, et al
     Using intravital microscopy to study the role of chemokines during infection and inflammation in the central nervous system.
     J Neuroimmunol. 2010;224.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. LIGOCKI AJ , Lovato L, Xiang D, Guidry P, et al
     A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. MENDEL I , Shoham A, Propheta-Meiran O, Ishai E, et al
     A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. DE SANTIS G , Ferracin M, Biondani A, Caniatti L, et al
     Altered miRNA expression in T regulatory cells in course of multiple sclerosis.
     J Neuroimmunol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
183. ALMOLDA B , Gonzalez B, Castellano B
     Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE.
     J Neuroimmunol. 2010;223.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. COMABELLA M , Montalban X, Kakalacheva K, Osman D, et al
     B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.
     J Neuroimmunol. 2010;223.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: